222 related articles for article (PubMed ID: 17984930)
1. Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease.
Suárez-Llanos JP; Fernández-Fernández E; Checa MR; Jara-Albarrán A
Neuro Endocrinol Lett; 2007 Oct; 28(5):549-53. PubMed ID: 17984930
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
3. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
[TBL] [Abstract][Full Text] [Related]
4. Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.
Jara-Albarran A; Bayort J; Caballero A; Portillo J; Laborda L; Sampedro M; Cure C; Mateos JM
J Clin Endocrinol Metab; 1979 Aug; 49(2):236-41. PubMed ID: 222793
[TBL] [Abstract][Full Text] [Related]
5. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
7. Octreotide exerts different effects in vivo and in vitro in Cushing's disease.
Stalla GK; Brockmeier SJ; Renner U; Newton C; Buchfelder M; Stalla J; Müller OA
Eur J Endocrinol; 1994 Feb; 130(2):125-31. PubMed ID: 8130885
[TBL] [Abstract][Full Text] [Related]
8. [Cushing's disease with corticotropic microadenoma and empty sella turcica].
Leutenegger M; Gross A; Hublot C
Nouv Presse Med; 1982 Feb; 11(6):454-5. PubMed ID: 6278400
[No Abstract] [Full Text] [Related]
9. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
Mannavola D; Persani L; Vannucchi G; Zanardelli M; Fugazzola L; Verga U; Facchetti M; Beck-Peccoz P
Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
[TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
[TBL] [Abstract][Full Text] [Related]
11. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
12. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
Yanase T; Sekiya K; Ando M; Nawata H; Kato K; Ibayashi H
Acta Endocrinol (Copenh); 1985 Sep; 110(1):36-41. PubMed ID: 2994336
[TBL] [Abstract][Full Text] [Related]
13. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells.
Hofland LJ; Lamberts SW; Feelders RA
Neuroendocrinology; 2010; 92 Suppl 1():11-6. PubMed ID: 20829612
[TBL] [Abstract][Full Text] [Related]
14. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)].
Nouedoui C; Moukouri E; Juimo AG; Dongmo L; Zok FD; Tapko JB; Muna WF
Tunis Med; 1999 Mar; 77(3):154-8. PubMed ID: 10392035
[No Abstract] [Full Text] [Related]
15. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature.
Gulcan E; Gulcan A; Taser F; Korkmaz U; Erbilen E
Neuro Endocrinol Lett; 2007 Dec; 28(6):745-8. PubMed ID: 18063931
[TBL] [Abstract][Full Text] [Related]
16. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide].
Mayinger B; Axelos D; Pavel M; Hahn EG; Hensen J
Dtsch Med Wochenschr; 1999 Jan; 124(4):73-8. PubMed ID: 10071603
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats.
Schmid HA; Silva AP
J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
[TBL] [Abstract][Full Text] [Related]
20. TSH secreting pituitary adenoma: a rare cause of thyrotoxicosis.
So WY; Yeung VT; Chow CC; Ko GT; Szeto CC; Cockram CS
Int J Clin Pract; 1998; 52(1):62-4. PubMed ID: 9536575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
